14.03.2013 • News

Borealis Acquires DEXPlastomers in Geleen

Borealis, a provider of innovative solutions in the fields of polyolefins, base chemicals and fertilizers, announced today that it has acquired DEXPlastomers in Geleen, The Netherlands, from DSM Nederland and ExxonMobil Benelux Holdings.

Until today, DEXPlastomers was a 50/50 joint venture ultimately owned by Royal DSM and ExxonMobil Chemical Company. The site is located in the Chemelot industrial park, 50 kilometres away from the nearest Borealis site in Beringen, Belgium.

Borealis has started the integration of the new site and its activities, a process in which safety and business continuity are key, to ensure continued punctual supply to customers.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read